Hepatitis C: all 2,356 studies
Page 10 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- HCV Self-testing in MalaysiaCompletedNCT04982718Not applicable
- CARES-HCV: Promoting Screening Uptake Among Diverse Baby BoomersCompletedNCT04980157
- HCV Self-testing in PakistanCompletedNCT04971538Not applicable
- HCV Self-testing in GeorgiaCompletedNCT04961723Not applicable
- Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University HospitalStatus unknownNCT04959643
- Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis CStatus unknownNCT04952207
- SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV PatientsStatus unknownNCT04948801
- Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the CommunityCompletedNCT04947475Not applicable
- Hepatitis C in Severe Mental Disorders: Nursing ProgrammeCompletedNCT04891445Not applicable
- 8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis CCompletedNCT04885855Phase 2/3
- Electronic Record Assimilation and Subsequent Eradication of Hepatitis CCompletedNCT04873609Not applicable
- Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating WomenStatus unknownNCT04852614
- A Cross Sectional Observational Study on Relation Between Oral Manifestation and Hepatitis C in EgyptCompletedNCT04812990
- Prisons Evaluation of a One-stop-shop InterVentiOnCompletedNCT04809246Not applicable
- The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 InfectionCompletedNCT04774107Phase 1
- HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
- Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?CompletedNCT04757272
- Increasing HCV Linkage to Care Among People Who Inject DrugsCompletedNCT04741750Not applicable
- HCV Reinfection in HD Patients Achieving SVRStatus unknownNCT04732832
- Occult HCV Infection After DAAD Treatment in Haemodialysis PatientsCompletedNCT04719338Not applicable
- Evaluation of the Use of the GenXpert to Detect Hepatitis C RNAStatus unknownNCT04717856Not applicable
- Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib AloneCompletedNCT04710641Phase 2
- Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-EntrantsActive, not recruitingNCT04701437Not applicable
- Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-respondersCompletedNCT04695769Phase 4
- A Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney TransplantationCompletedNCT04682509Early Phase 1
- European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric ProtocolStatus unknownNCT04677842
- Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus RelapseStatus unknownNCT04662138
- HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled TrialCompletedNCT04653818Phase 4
- HCV Treatment Initiation During Acute Psychiatric AdmissionStatus unknownNCT04625322Phase 4
- Application of 18F-FDOPA PET in Research of the Association Between HCV Infection and Parkinson's Disease.Status unknownNCT04618679
- Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis AccessWithdrawnNCT04614142Phase 4
- HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in BrusselsCompletedNCT04610762
- Study on the Prevalence of Hepatitis C In a psychiatRic PopulationCompletedNCT04600479Not applicable
- Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ DonorCompletedNCT04596475Phase 1/2
- Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological ResponseCompletedNCT04577482
- Leptin and Liver Enzymes Responses to Aerobic Training in Hepatitis c PatientsStatus unknownNCT04550273Not applicable
- HepATocellular Cancer Hcv Therapy StudyWithdrawnNCT04546802Phase 3
- Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in CirrhosisStatus unknownNCT04543643Phase 3
- Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER CancerCompletedNCT04540081Not applicable
- Improving Inpatient Screening for Hepatitis CCompletedNCT04525690Not applicable
- Link Hepatitis C Notifications to Treatment in TasmaniaStatus unknownNCT04510246Not applicable
- A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant RecipientsActive, not recruitingNCT04508907Phase 4
- Testing of a Navigation Intervention for Hepatitis C and HIVTerminatedNCT04499651Not applicable
- Re-linkage to Care of Patients With Hepatitis CStatus unknownNCT04470271
- Prediction of Liver-related Outcomes After HCV CureStatus unknownNCT04460157
- Effect of Hepatitis C Clearance on Insulin ResistanceCompletedNCT04457050Phase 4
- Screening for Chronic Hepatitis C Virus in Hospitalized PatientsCompletedNCT04437277Not applicable
- A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe ProgramsStatus unknownNCT04428346Not applicable
- Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized PatientsTerminatedNCT04405024Not applicable
- STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTsWithdrawnNCT04395118Not applicable
- Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 PatientsCompletedNCT04391985Phase 1/2
- P300 in Early Cognitive Impairment in Hepatitis C VirusCompletedNCT04389268
- ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced ParticipantsCompletedNCT04387539Phase 1/2
- Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4CompletedNCT04387526Phase 2/3
- Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian PatientsCompletedNCT04385407Phase 2
- Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 InfectionCompletedNCT04382937Phase 3
- Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4CompletedNCT04382339Phase 1/2
- Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4CompletedNCT04378608Phase 1/2
- A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction CentersCompletedNCT04366973
- HBV/HCV/HIV in Belgian PrisonsCompletedNCT04366492Not applicable
- Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral InfectionsCompletedNCT04363411Not applicable
- PK of SOF/LED in HCV - Infected Adolescents With Haematological DisordersStatus unknownNCT04353986Phase 3
- Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver CirrhosisCompletedNCT04352309
- Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical TrialCompletedNCT04330508
- Pharmacist-led Hepatitis C ManagementStatus unknownNCT04322981Phase 4
- HCV + to HCV - Kidney TransplantWithdrawnNCT04320290Phase 4
- Therapeutic Hepatitis C Virus VaccineStatus unknownNCT04318379Phase 1
- DBS Evaluation of Fujirebio INNOTEST® HCV Ab IVCompletedNCT04317729Not applicable
- Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected SubjectsWithdrawnNCT04309734Phase 1/2
- Rapid HCV RNA Testing and LInkage to CareTerminatedNCT04302948Not applicable
- An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis CStatus unknownNCT04301882
- HCV Reinfection After DAA Therapy in PWID in BelgiumStatus unknownNCT04251572Not applicable
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1CompletedNCT04246723Phase 2
- Expression of Inflammasomes in HCV PatientsStatus unknownNCT04244383Phase 4
- HCV RAS Testing in Public Health ProgramsStatus unknownNCT04242433
- Truenat™ HCV RNA Assay EvaluationCompletedNCT04236973Not applicable
- Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)WithdrawnNCT04235049Phase 4
- Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy SubjectsCompletedNCT04232514Phase 1
- Opportunstic Hepatitis C Virus TreatmentCompletedNCT04220645Not applicable
- Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis CStatus unknownNCT04220151
- A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C VirusCompletedNCT04214028
- Metabolic Changes in Chronic HCV Patients Receiving DAASStatus unknownNCT04211844
- Hepatitis C Elimination in the NetherlandsStatus unknownNCT04208035
- The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected SubjectsCompletedNCT04202952Phase 1/2
- Voices From the Black Community: Hepatitis C Research ParticipationCompletedNCT04202081
- The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected SubjectsCompletedNCT04201275Phase 1
- GastrOesophageal Varices After Sustained Virological ResponseStatus unknownNCT04191018
- A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian FederationCompletedNCT04189627
- Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 VillagesCompletedNCT04177043Phase 4
- Future Destinations: Journeys Towards CitizenshipCompletedNCT04159545
- Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir in Patients With Hepatitis CStatus unknownNCT04159246
- Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With MenStatus unknownNCT04156945Not applicable
- Retrieval of Hepatitis C Patients Lost to Follow-upStatus unknownNCT04153708Not applicable
- Evaluation Study of HCV RDTs in Fresh SamplesCompletedNCT04139941
- Development and Pilot Testing of a PHCI for Emergency Department Patients Who Decline Rapid HIV/ HCV ScreeningCompletedNCT04137094Not applicable
- Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina FasoStatus unknownNCT04136405
- the Pulmonary Safety of Antihepatitis C TreatmentStatus unknownNCT04122066
- Simplified Monitoring Myanmar SM2 StudyCompletedNCT04113629Not applicable
- Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection PatientsStatus unknownNCT04111367Phase 2
- Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus InfectionCompletedNCT04094272